MedTrace Logo

The Effect of TASH in Patients With HOCM

NCT04066777 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2023-11-18

No results posted yet for this study

Summary

To examine patients with hypertrophic obstructive cardiomyopathy (HOCM) before and after septal alcohol ablation, to investigate the effect of the treatment in regards to changes in myocardial function, perfusion, invasive hemodynamics and exercise tolerance.

Conditions

  • Hypertrophic Obstructive Cardiomyopathy

Interventions

PROCEDURE

alcohol septal ablation

injection of 1-4 mL of 96% ethanol into a septal perforator of the left anterior coronary artery to produce a myocardial infarction

Sponsors & Collaborators

  • Steen Hvitfeldt Poulsen

    lead OTHER

Principal Investigators

  • Steen Hvitfeldt Poulsen, DMSc · Aarhus University Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-29
Primary Completion
2023-10-01
Completion
2023-10-01

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04066777 on ClinicalTrials.gov